A Facile Access to Green Fluorescent Albumin Derivatives

Chembiochem. 2024 Apr 16;25(8):e202300862. doi: 10.1002/cbic.202300862. Epub 2024 Mar 13.

Abstract

A Morita-Baylis-Hillman Adduct (MBHA) derivative bearing a triphenylamine moiety was found to react with human serum albumin (HSA) shifting its emission from the blue to the green-yellow thus leading to green fluorescent albumin (GFA) derivatives and enlarging the platform of probes for aggregation-induced fluorescent-based detection techniques. A possible interaction of MBHA derivative 7 with a lipophilic pocket within the HSA structure was suggested by docking studies. DLS experiments showed that the reaction with HSA induce a conformational change of the protein contributing to the aggregation process of GFA derivatives. The results of investigations on the biological properties suggested that GFA retained the ability of binding drug molecules such as warfarin and diazepam. Finally, cytotoxicity evaluation studies suggested that, although the MBHA derivative 7 at 0.1 μg/mL affected the percentage of cell viability in comparison to the negative control, it cannot be considered cytotoxic, whereas at all the other concentrations≥0.5 μg/mL resulted cytotoxic at different extent.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Humans
  • Molecular Docking Simulation
  • Protein Binding
  • Proteins / metabolism
  • Serum Albumin, Human / chemistry
  • Spectrometry, Fluorescence

Substances

  • Antineoplastic Agents
  • Proteins
  • Serum Albumin, Human